BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26895105)

  • 21. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma microRNA-9 as a diagnostic and prognostic biomarker in patients with esophageal squamous cell carcinoma.
    Cui Y; Xue Y; Dong S; Zhang P
    J Int Med Res; 2017 Aug; 45(4):1310-1317. PubMed ID: 28587538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of prognostic miRNA biomarkers for esophageal cancer based on The Cancer Genome Atlas and Gene Expression Omnibus.
    Xue J; Jia E; Ren N; Xin H
    Medicine (Baltimore); 2021 Feb; 100(7):e24832. PubMed ID: 33607850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma.
    Li WQ; Hu N; Burton VH; Yang HH; Su H; Conway CM; Wang L; Wang C; Ding T; Xu Y; Giffen C; Abnet CC; Goldstein AM; Hewitt SM; Taylor PR
    Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1579-1588. PubMed ID: 24867265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
    Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
    J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of ISG15 mRNA level in drinkers with esophageal squamous cell cancers.
    Tao J; Hua P; Wen J; Hu Y; Yang H; Xie X
    Int J Clin Exp Pathol; 2015; 8(9):10975-84. PubMed ID: 26617815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
    Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
    Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
    Sun J; Song K; Feng X; Gao S
    Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
    Li J; Li M; Gao F; Ge X
    Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of
    Kwon D; Yun JY; Keam B; Kim YT; Jeon YK
    World J Gastroenterol; 2016 Nov; 22(44):9803-9812. PubMed ID: 27956804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-421 expression independently predicts unfavorable overall survival in patients with esophageal adenocarcinoma.
    Lin XF; Zhang CQ; Dong BR
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3790-3798. PubMed ID: 31115005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
    Song C; Lu P; Shi W; Sun G; Wang G; Huang X; Wang Z; Wang Z
    Biomed Pharmacother; 2016 Oct; 83():843-849. PubMed ID: 27501502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic value of miR-92a in patients with gastric cancer.
    Ren C; Wang W; Han C; Chen H; Fu D; Luo Y; Yao H; Wang D; Ma L; Zhou L; Han D; Shen M
    Tumour Biol; 2016 Jul; 37(7):9483-91. PubMed ID: 26790436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
    Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
    Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
    Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
    PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
    Luo HS; Wu DH
    Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
    Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
    J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
    Wang C; Guan S; Liu F; Chen X; Han L; Wang D; Nesa EU; Wang X; Bao C; Wang N; Cheng Y
    Br J Cancer; 2016 Feb; 114(3):290-7. PubMed ID: 26794279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.